Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PRME

Prime Medicine Inc

Apr 26 • 04:00PM ET

4.43

Dollar change +0.12
Percentage change 2.91	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI ARKG VB ARKK VBK VXF IWM IWO IBB VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.14	Insider Own	58.50%	Shs Outstand	97.38M	Perf Week	-1.88%
Market Cap	530.73M	Forward P/E	-	EPS next Y	-1.60	Insider Trans	15.85%	Shs Float	49.77M	Perf Month	-34.54%
Income	-198.13M	PEG	-	EPS next Q	-0.45	Inst Own	27.56%	Short Float	20.52%	Perf Quarter	-32.24%
Sales	0.00M	P/S	-	EPS this Y	18.56%	Inst Trans	-	Short Ratio	14.08	Perf Half Y	-27.76%
Book/sh	1.37	P/B	3.24	EPS next Y	10.15%	ROA	-52.99%	Short Interest	10.21M	Perf Year	-66.58%
Cash/sh	1.01	P/C	4.36	EPS next 5Y	-	ROE	-88.19%	52W Range	4.11 - 17.20	Perf YTD	-50.06%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-193.88%	ROI	-144.17%	52W High	-74.27%	Beta	2.22
Dividend TTM	-	Quick Ratio	2.53	Sales past 5Y	-25.00%	Gross Margin	-	52W Low	7.66%	ATR (14)	0.45
Dividend Ex-Date	Sep 10, 2019	Current Ratio	2.53	EPS Y/Y TTM	-45.24%	Oper. Margin	0.00%	RSI (14)	28.39	Volatility	10.36% 7.50%
Employees	234	Debt/Eq	0.10	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.50	Target Price	15.50
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	-61.42%	Payout	-	Rel Volume	0.87	Prev Close	4.30
Sales Surprise	-100.00%	EPS Surprise	-29.50%	Sales Q/Q	-	Earnings	Mar 01 BMO	Avg Volume	725.56K	Price	4.43
SMA20	-19.87%	SMA50	-36.19%	SMA200	-50.36%	Trades		Volume	632,922	Change	2.91%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-24	Initiated	Chardan Capital Markets	Buy	$17
Apr-08-24	Initiated	TD Cowen	Buy
Apr-03-24	Initiated	Wedbush	Outperform	$12
Jan-16-24	Downgrade	Stifel	Buy → Hold	$18 → $9
Dec-08-23	Initiated	Citigroup	Neutral	$10
Oct-09-23	Initiated	BMO Capital Markets	Outperform	$19
Jul-31-23	Initiated	Guggenheim	Buy	$24
Apr-18-23	Initiated	Stifel	Buy	$18
Nov-14-22	Initiated	Morgan Stanley	Equal-Weight	$23
Nov-14-22	Initiated	JP Morgan	Overweight	$27
Nov-14-22	Initiated	Jefferies	Buy	$25
Nov-14-22	Initiated	Goldman	Neutral	$22

Show Previous Ratings

Apr-23-24 08:00AM	Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings (GlobeNewswire)
Mar-27-24 08:45AM	2 Magnificent Growth Stocks With Room to Run (Motley Fool)
Mar-14-24 02:44PM	Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging (InvestorPlace) -13.18%
Mar-01-24 02:00PM	Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? (InvestorPlace)
08:00AM	Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
03:02AM	Loading…
Feb-29-24 03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey) -5.99%
Feb-28-24 08:00AM	Prime Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-20-24 04:01PM	Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -5.08%
Feb-14-24 11:50PM	Prime Medicine Announces Pricing of Upsized Public Offering (GlobeNewswire)
04:05PM	Prime Medicine Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Feb-01-24 08:00AM	Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference (GlobeNewswire) +5.67%
Jan-25-24 08:00AM	Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE Prime Editors for Cystic Fibrosis (GlobeNewswire)
Jan-09-24 06:21PM	Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know (Zacks)
Jan-05-24 05:00PM	Prime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes (PR Newswire)
08:00AM	Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer (GlobeNewswire)
08:00AM	Loading…
Jan-02-24 08:00AM	Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-19-23 10:30AM	Better Growth Stock: Archer Aviation or Prime Medicine? (Motley Fool) +6.73%
Nov-30-23 07:45AM	1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years (Motley Fool)
Nov-08-23 08:00AM	Prime Medicine to Present at Upcoming Investor Conferences (GlobeNewswire) -9.75%
Nov-03-23 04:01PM	Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) +17.65%
Oct-30-23 03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
Oct-27-23 06:00AM	Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b (GlobeNewswire) -6.60%
Oct-24-23 07:30AM	Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases (GlobeNewswire)
05:04AM	The Bull Market Can Continue to Roll On; BMOs Brian Belski Predicts Further Gains for Stocks Here Are 3 Names to Play That Bullish Sentiment (TipRanks)
Oct-23-23 02:50AM	7 Biotech Stocks to Get In Now Before Investors Catch On (InvestorPlace)
Oct-17-23 08:00AM	Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences (GlobeNewswire) +10.00%
Oct-09-23 09:33AM	Oracle upgraded, Spotify downgraded: Wall Street's top analyst calls (The Fly)
Sep-19-23 08:00AM	Prime Medicine to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-31-23 08:00AM	Prime Medicine to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-07-23 04:01PM	Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -8.66%
07:45AM	Loading…
Jul-25-23 07:45AM	2 Cathie Wood Stocks That Could Be Hidden Gems (Motley Fool)
Jun-29-23 08:46AM	We're Hopeful That Prime Medicine (NASDAQ:PRME) Will Use Its Cash Wisely (Simply Wall St.)
Jun-22-23 08:00AM	Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome (GlobeNewswire)
Jun-02-23 10:15AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) +9.15%
May-31-23 08:00AM	Prime Medicine to Present at Investor Conferences in June (GlobeNewswire)
May-26-23 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
May-17-23 04:05PM	Prime Medicine to Present at Virtual Investor Conferences in May (GlobeNewswire)
06:00AM	Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting (GlobeNewswire)
May-11-23 08:00AM	Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -10.61%
Mar-27-23 08:00AM	Prime Medicine to Present at Guggenheim Healthcare Talks Genomic Medicines and Rare Disease Days (GlobeNewswire) +5.89%
Mar-09-23 08:00AM	Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-27-23 08:00AM	Prime Medicine to Present at Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Jan-20-23 05:56AM	We Think Prime Medicine (NASDAQ:PRME) Needs To Drive Business Growth Carefully (Simply Wall St.)
Jan-09-23 07:00AM	Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities (GlobeNewswire)
Jan-03-23 08:00AM	Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.60%
Nov-01-22 04:13PM	After Prime Medicine, What's the Next Gene Editing IPO? (TheStreet.com) +12.22%
Oct-24-22 05:30PM	Prime Medicine Announces Closing of Upsized Initial Public Offering (GlobeNewswire)
Oct-20-22 12:45PM	UPDATE 1-Biotech firm Prime Medicine valued at $1.8 bln in strong debut (Reuters)
Oct-19-22 09:47PM	Prime Medicine Announces Pricing of Upsized Initial Public Offering (Business Wire)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ARCH Venture Partners XII, LLC	10% Owner	Feb 15 '24	Buy	6.25	3,200,000	20,000,000	3,200,000	Feb 20 05:38 PM
ARCH Venture Partners X, LLC	10% Owner	Feb 15 '24	Buy	6.25	3,200,000	20,000,000	3,200,000	Feb 20 05:37 PM
NELSEN ROBERT	Director	Feb 15 '24	Buy	6.25	3,200,000	20,000,000	3,200,000	Feb 20 05:41 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 21 '23	Sale	14.97	19,003	284,496	0	Jun 22 05:03 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 20 '23	Sale	15.06	37,405	563,248	0	Jun 22 05:03 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 16 '23	Sale	15.02	6,532	98,109	0	Jun 20 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 15 '23	Sale	14.92	66,659	994,326	0	Jun 20 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 14 '23	Sale	14.87	28,960	430,684	0	Jun 15 04:22 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 13 '23	Sale	15.13	28,100	425,102	0	Jun 15 04:22 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 12 '23	Sale	14.98	16,031	240,151	0	Jun 13 04:20 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 09 '23	Sale	14.48	15,672	226,984	0	Jun 13 04:20 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 08 '23	Sale	15.74	5,000	78,686	0	Jun 09 04:24 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 07 '23	Sale	16.92	15,000	253,871	0	Jun 09 04:24 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 06 '23	Sale	17.02	29,975	510,166	0	Jun 07 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 05 '23	Sale	16.70	22,434	374,612	0	Jun 07 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 01 '23	Sale	14.36	45,223	649,194	0	Jun 02 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 31 '23	Sale	13.65	16,633	227,004	0	Jun 02 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 30 '23	Sale	13.70	16,805	230,240	0	May 31 04:15 PM
GV 2019 GP, L.L.C.	10% Owner	May 26 '23	Sale	13.70	12,602	172,603	0	May 31 04:15 PM
GV 2019 GP, L.L.C.	10% Owner	May 25 '23	Sale	13.38	23,161	309,973	0	May 26 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 24 '23	Sale	13.66	7,900	107,920	0	May 26 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 23 '23	Sale	14.74	43,939	647,648	0	May 24 05:07 PM
GV 2019 GP, L.L.C.	10% Owner	May 22 '23	Sale	14.13	87,922	1,242,092	0	May 24 05:07 PM
GV 2019 GP, L.L.C.	10% Owner	May 19 '23	Sale	13.88	63,212	877,066	0	May 22 04:21 PM
GV 2019 GP, L.L.C.	10% Owner	May 18 '23	Sale	13.04	27,098	353,271	0	May 22 04:21 PM
GV 2019 GP, L.L.C.	10% Owner	May 17 '23	Sale	12.77	15,000	191,600	10,735,324	May 18 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 16 '23	Sale	12.59	50,649	637,676	10,750,324	May 18 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 15 '23	Sale	12.74	157,952	2,012,087	10,800,973	May 16 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 12 '23	Sale	12.72	27,290	347,222	10,958,925	May 16 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 11 '23	Sale	13.13	26,626	349,533	10,986,215	May 12 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 10 '23	Sale	14.03	87,397	1,225,804	11,012,841	May 12 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 09 '23	Sale	14.08	321,238	4,522,613	11,100,238	May 10 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 08 '23	Sale	14.13	100,772	1,423,727	11,421,476	May 10 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRME

Prime Medicine Inc

Upgrade your FINVIZ experience